These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15063141)

  • 1. Suppression of intestinal polyposis in Apcmin/+ mice by targeting the nitric oxide or poly(ADP-ribose) pathways.
    Mabley JG; Pacher P; Bai P; Wallace R; Goonesekera S; Virag L; Southan GJ; Szabó C
    Mutat Res; 2004 Apr; 548(1-2):107-16. PubMed ID: 15063141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production.
    Ahn B; Ohshima H
    Cancer Res; 2001 Dec; 61(23):8357-60. PubMed ID: 11731407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberration of poly(adenosine diphosphate-ribose) metabolism in human colon adenomatous polyps and cancers.
    Hirai K; Ueda K; Hayaishi O
    Cancer Res; 1983 Jul; 43(7):3441-6. PubMed ID: 6406058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inhibitor of inducible nitric oxide synthase and scavenger of peroxynitrite prevents diabetes development in NOD mice.
    Suarez-Pinzon WL; Mabley JG; Strynadka K; Power RF; Szabó C; Rabinovitch A
    J Autoimmun; 2001 Jun; 16(4):449-55. PubMed ID: 11437493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
    Yekkala K; Baudino TA
    Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular targets against mustard toxicity: implication of cell surface receptors, peroxynitrite production, and PARP activation.
    Korkmaz A; Yaren H; Topal T; Oter S
    Arch Toxicol; 2006 Oct; 80(10):662-70. PubMed ID: 16552503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-Catenin-accumulated crypts in the colonic mucosa of juvenile ApcMin/+ mice.
    Hata K; Tanaka T; Kohno H; Suzuki R; Qiang SH; Yamada Y; Oyama T; Kuno T; Hirose Y; Hara A; Mori H
    Cancer Lett; 2006 Jul; 239(1):123-8. PubMed ID: 16168560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PARP-1 modulates deferoxamine-induced HIF-1alpha accumulation through the regulation of nitric oxide and oxidative stress.
    Martínez-Romero R; Martínez-Lara E; Aguilar-Quesada R; Peralta A; Oliver FJ; Siles E
    J Cell Biochem; 2008 Aug; 104(6):2248-60. PubMed ID: 18459142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice.
    Swamy MV; Patlolla JM; Steele VE; Kopelovich L; Reddy BS; Rao CV
    Cancer Res; 2006 Jul; 66(14):7370-7. PubMed ID: 16849589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of intestinal polyposis in Mdr1-deficient ApcMin/+ mice.
    Yamada T; Mori Y; Hayashi R; Takada M; Ino Y; Naishiro Y; Kondo T; Hirohashi S
    Cancer Res; 2003 Mar; 63(5):895-901. PubMed ID: 12615699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein tyrosine nitration and poly(ADP-ribose) polymerase activation in N-methyl-N-nitro-N-nitrosoguanidine-treated thymocytes: implication for cytotoxicity.
    Bai P; Hegedus C; Erdélyi K; Szabó E; Bakondi E; Gergely S; Szabó C; Virág L
    Toxicol Lett; 2007 May; 170(3):203-13. PubMed ID: 17428624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands.
    Niho N; Takahashi M; Kitamura T; Shoji Y; Itoh M; Noda T; Sugimura T; Wakabayashi K
    Cancer Res; 2003 Sep; 63(18):6090-5. PubMed ID: 14522940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hindlimb ischemia/reperfusion-induced remote injury to the small intestine: role of inducible nitric-oxide synthase-derived nitric oxide.
    Katada K; Bihari A; Badhwar A; Yoshida N; Yoshikawa T; Potter RF; Cepinskas G
    J Pharmacol Exp Ther; 2009 Jun; 329(3):919-27. PubMed ID: 19270191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult Apc(Min/+) mice.
    Yamada Y; Hata K; Hirose Y; Hara A; Sugie S; Kuno T; Yoshimi N; Tanaka T; Mori H
    Cancer Res; 2002 Nov; 62(22):6367-70. PubMed ID: 12438216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired mitochondrial function induced by serum from septic shock patients is attenuated by inhibition of nitric oxide synthase and poly(ADP-ribose) synthase.
    Boulos M; Astiz ME; Barua RS; Osman M
    Crit Care Med; 2003 Feb; 31(2):353-8. PubMed ID: 12576936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combined inducible nitric oxide synthase inhibitor and free radical scavenger guanidinoethyldisulfide prevents multiple low-dose streptozotocin-induced diabetes in vivo and interleukin-1beta-induced suppression of islet insulin secretion in vitro.
    Mabley JG; Southan GJ; Salzman AL; Szabó C
    Pancreas; 2004 Mar; 28(2):E39-44. PubMed ID: 15028959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of poly (ADP-ribose) polymerase attenuates acute lung injury in an ovine model of sepsis.
    Murakami K; Enkhbaatar P; Shimoda K; Cox RA; Burke AS; Hawkins HK; Traber LD; Schmalstieg FC; Salzman AL; Mabley JG; Komjáti K; Pacher P; Zsengellér Z; Szabó C; Traber DL
    Shock; 2004 Feb; 21(2):126-33. PubMed ID: 14752285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of nitric oxide (NO) and TNF-alpha in the oxidative stress associated with anemia in experimental Trypanosoma cruzi infection.
    Malvezi AD; Cecchini R; de Souza F; Tadokoro CE; Rizzo LV; Pinge-Filho P
    FEMS Immunol Med Microbiol; 2004 May; 41(1):69-77. PubMed ID: 15094169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of NO synthases in arginine-dependent small intestinal and colonic carcinogenesis.
    Yerushalmi HF; Besselsen DG; Ignatenko NA; Blohm-Mangone KA; Padilla-Torres JL; Stringer DE; Cui H; Holubec H; Payne CM; Gerner EW
    Mol Carcinog; 2006 Feb; 45(2):93-105. PubMed ID: 16329147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC(Min/+) mice.
    Koehl GE; Spitzner M; Ousingsawat J; Schreiber R; Geissler EK; Kunzelmann K
    Oncogene; 2010 Mar; 29(10):1553-60. PubMed ID: 19966863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.